ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Preserving Function in Breast Cancer Patients

This study is currently recruiting participants.
Verified by Dartmouth-Hitchcock Medical Center, May 2008

Sponsored by: Dartmouth-Hitchcock Medical Center
Information provided by: Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT00429286
  Purpose

Breast cancer patients experience functional limitations related to the cancer and treatment side effects. Early functional limitations affect short- and long-term quality of life, and may lead to long-term complications. Patients living in rural areas are at particular risk because they do not have easy access to services. Therefore, early intervention is indicated to have an impact on the overall public health. Problem solving training (PST) is a standardized manual driven intervention that may be ideally suited to assist breast cancer patients to preserve their valued activities and to comply with recommended symptom management regimens (e.g., physical therapy, aerobic exercise and relaxation/guided imagery) that improve function. Telephone-based PST provided from a centralized location (such as the comprehensive cancer center) may improve access and outcomes in a cost-effective manner. We propose to conduct a feasibility study of a PST intervention with 30 rural breast cancer patients undergoing adjuvant treatment randomly assigned to PST or to usual care. The intervention group will receive weekly phone-based PST sessions for six consecutive weeks. The specific aims of this R03 small grant application are to:1) Test the feasibility of enrolling and retaining newly diagnosed breast cancer patients in a clinical trial to assess telephone-based PST. 2) Collect preliminary data on outcome measures of function to determine effect size estimates that will inform power analyses for a full scale randomized controlled study. Primary outcome measures will be acceptance rates for enrollment in the study, retention rates across both intervention arms, and satisfaction levels with the PST intervention. Assessments will be conducted at baseline, and at six weeks (end of PST intervention) and 3 months following baseline. The long-term goal of this line of investigation is to develop practical, widely applicable rehabilitation models of care to preserve function and decrease distress in cancer patients undergoing treatment.


Condition Intervention
Breast Cancer
Behavioral: Problem Solving Training

Genetics Home Reference related topics:   breast cancer   

MedlinePlus related topics:   Breast Cancer    Cancer   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Cohort, Prospective
Official Title:   Preserving Function in Rural Breast Cancer Patients Undergoing Chemotherapy

Further study details as provided by Dartmouth-Hitchcock Medical Center:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   30
Study Start Date:   May 2007
Estimated Study Completion Date:   August 2008

Intervention Details:
    Behavioral: Problem Solving Training
    A systematic cognitive-behavioral intervention teaching problem solving skills for addressing functional impairment related to breast cancer and its treatment.
  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample

Study Population

Breast cancer patients undergoing chemotherapy at the Norris Cotton Cancer Center in Lebanon, NH.


Criteria

Inclusion Criteria:

  1. Females, age > 18 years.
  2. First breast cancer diagnosis, Stages 1-3.
  3. Beginning the second chemotherapy cycle.
  4. English speaking and literate.

Exclusion Criteria:

  1. Previous or concurrent malignancy, except for non-melanotic skin cancers.
  2. Lifetime diagnosis of schizophrenia or bipolar disorder.
  3. Moderate-severe cognitive impairment indicated by a score < 3 on a 6-item cognitive screener.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00429286

Contacts
Contact: Mark T Hegel, PhD     603.650.7539     mark.hegel@dartmouth.edu    

Locations
United States, New Hampshire
Dartmouth-Hitchcock Medical Center     Recruiting
      Lebanon, New Hampshire, United States, 03756
      Principal Investigator: Mark T Hegel, PhD            

Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center

Investigators
Principal Investigator:     Mark T Hegel, PhD     Dartmouth-Hitchcock Medical Center    
  More Information


Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, NH  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Dartmouth College ( Mark Hegel )
Study ID Numbers:   1 R03 CA124200-01
First Received:   January 29, 2007
Last Updated:   May 5, 2008
ClinicalTrials.gov Identifier:   NCT00429286
Health Authority:   United States: Federal Government

Keywords provided by Dartmouth-Hitchcock Medical Center:
Health Services Research  

Study placed in the following topic categories:
Skin Diseases
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers